Alzheimer’s Disease is frequently associated with many things: memory loss, the inability to care for one’s self, an increased likelihood of wandering off or becoming lost, fear and (perhaps most importantly) the lack of a cure.
The disease is prominent; it’s the 6th leading cause of death in the United States and that figure is likely to increase. Between 2010 and 2015, the prevalence of Alzheimer’s cases grew by 125%. In stark figures, Alzheimer’s is responsible for more deaths than breast cancer and prostate cancer, combined.
Often times, the burden of care lies on family members and other unpaid individuals due to high costs and a lack of options.
While researchers continue to search for a cure, and while early diagnosis techniques are improving, there may be hope for current sufferers: CBD.
As a neurodegenerative disease that progresses over time, sometimes more rapidly than others, the disease attacks the brain and various neuroreceptors of sufferers. A few of the hallmarks of the disease, only identified post mortem, are plaque build-up in the brain and inflammation. Each of these affects the cognitive abilities of patients.
Multiple treatments designed to reduce the effects of the disorder exist, but none are able to stop the physical momentum of Alzheimer’s in its progression forward.
In one study, published in the Journal of Alzheimer’s Disease, researchers sought to study whether CBD’s known and proven anti-inflammatory and anti-oxidative properties could help reduce the symptoms of sufferers.
While the study was performed on mice, the results were promising. CBD was shown to reduce – and in some cases, remove – cognitive impairment and the inability to recognize familiar objects and structures in the rodents that were studied.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.